Examination Report |
1 | TM-16 | 13 Aug 2013 |
10 | TM-1 | |
2 | Letter | 13 Nov 2014 |
3 | Reply to Exam Report (MIS-R) | 26 Feb 2016 |
4 | Journal Copy | 01 Mar 2018 |
5 | TM-O(NOTICE OF OPPOSITION) | 22 Mar 2018 |
6 | Letters related to TOP | 05 Oct 2018 |
7 | Annexure -1 under rule 46 | 26 Oct 2018 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 26 Oct 2018 |
8 | Annexure -1 under rule 46 | 26 Oct 2018 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 26 Oct 2018 |
9 | Applicant's affidavit Rule | 29 Oct 2018 |
1 | Dispatching of Examination Report for : 2479659 | 2767763 | 1387060 | 13 Jan 2016 |
2 | Hearing Notice (Show Cause) | 5300169 | 2327201 | 27 Oct 2017 |
3 | Tribunal ABA Notice for : 2479659 | 5442490 | 2413150 | 22 Nov 2017 |
4 | Opposition Notice | 6503985 | 2899905 | 14 Jun 2018 |
5 | Opposition Counter Statement | 6978158 | 3201896 | 12 Sep 2018 |
The application for Maxquin was made on 18 February 2013.
The trademark applicant for Maxquin is SUN PHARMA LABORATORIES.
Maxquin is applied in class(es) 5.
Application for Maxquin is on Opposed stage.
Application Id allotted to Maxquin is 2479659.
Maxquin filed with the Intellectual property office as a DEVICE.